Literature DB >> 2500550

A case of anorexia nervosa associated with epileptic seizures showing favorable responses to sodium valproate and clonazepam.

N Tachibana1, Y Sugita, Y Teshima, Y Hishikawa.   

Abstract

We reported the case of a 13-year-old anorectic girl with epileptic seizures who showed marked favorable responses to sodium valproate and clonazepam. These two anticonvulsants were effective not only for controlling her epileptic seizures, but also against anorexia nervosa itself. The mechanism of their action to anorexia nervosa is unknown, but repeated EEGs and a trial of sodium valproate with or without clonazepam may be useful in evaluating the diverse pathologies of anorexia nervosa which seems to be a heterogeneous clinical entity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500550     DOI: 10.1111/j.1440-1819.1989.tb02554.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  6 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Transcultural aspects of eating disorders: a critical literature review.

Authors:  C Davis; J Yager
Journal:  Cult Med Psychiatry       Date:  1992-09

Review 3.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

Review 4.  Eating disorders in the Far East.

Authors:  G Tsai
Journal:  Eat Weight Disord       Date:  2000-12       Impact factor: 4.652

Review 5.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa.

Authors:  L M Huckins; K Hatzikotoulas; L Southam; L M Thornton; J Steinberg; F Aguilera-McKay; J Treasure; U Schmidt; C Gunasinghe; A Romero; C Curtis; D Rhodes; J Moens; G Kalsi; D Dempster; R Leung; A Keohane; R Burghardt; S Ehrlich; J Hebebrand; A Hinney; A Ludolph; E Walton; P Deloukas; A Hofman; A Palotie; P Palta; F J A van Rooij; K Stirrups; R Adan; C Boni; R Cone; G Dedoussis; E van Furth; F Gonidakis; P Gorwood; J Hudson; J Kaprio; M Kas; A Keski-Rahkonen; K Kiezebrink; G-P Knudsen; M C T Slof-Op 't Landt; M Maj; A M Monteleone; P Monteleone; A H Raevuori; T Reichborn-Kjennerud; F Tozzi; A Tsitsika; A van Elburg; D A Collier; P F Sullivan; G Breen; C M Bulik; E Zeggini
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.